Check out this Q&A with Mathieu Seynaeve, psychiatrist and clinical researcher.
Read morePsychedelic Science Conference- Review
Here’s another review of the recent Psychedelic Science conference.
It sounds like a mixed bag, as the psychedelic renaissance continues to have growing pains.
Microdosing Mushrooms? Results Are Still Mixed.
Microdosing psychedelics has benefits, users say. Science isn’t convinced.
Read moreSense of Self
Researchers identified a small structure in the brain, the anterior precuneus or aPCu, as a crucial component in establishing our physical self or “I”. Keep reading and watch the video here.
Read moreMore on the Therapeutic Potential of Mushrooms
Fred Barrett, a neuroscientist at the Johns Hopkins Center for Psychedelic & Consciousness Research, discusses the revolutionary healing potential of psilocybin, what is not yet known about the compound’s role in treating various psychiatric disorders, the importance of the “therapy” aspect of psychedelic-assisted therapy, and the hurdles that remain to this treatment being accessible to the general public.
Read morePsychedelics and Antidepressants
5 Questions for psychopharmacologist Kelan Thomas. Thomas discusses what we know — and don’t know — about potential interactions between psychedelics and SSRIs.
Read moreStudying Psychedelics- Design and Research
How much does a person’s subjective experience and expectation of a psychedelic trip, as opposed to only the drug’s chemical effects on the brain, influence the drug’s ability to alleviate conditions like depression, addiction, or post-traumatic stress disorder?
Read morePsychedelics and Self-Treatment
Positive changes were observed across all 17 outcome items, with the strongest benefits on items related to insight and mood.
Read morePsilocybin and Lyme Disease?
Psilocybin is both serotonergic and anti-inflammatory and therefore may offer significant therapeutic benefits to patients with mental illness secondary to autoimmune inflammation.
Read moreLSD, Psychosis and Healing
The link between psychosis model and therapeutic model seems to lie in mystical experiences.
The results point to the importance of meaning attribution for the LSD psychosis model and indicate that psychedelic-assisted therapy might benefit from therapeutic suggestions fostering mystical experiences.
Read moreKetamine for Adolescents?
Their courses varied, but each had symptomatic and functional improvements, and the ketamine treatment was well-tolerated.
Read more